Patents/Inventors

Ravindra Kumar

Cambridge, MAUS49 patents

39 Patents

US125839062026
Actrii Proteins and Use in Treating Post-capillary Pulmonary Hypertension
ACCELERON PHARMA Inc.
0 cites
US125857792026
Secure Programming of One-time-programmable (OTP) Memory
Microchip Technology Incorporated
0 cites
US125668742026
Peripheral Access Control Using Bitmasks Indicating Access Settings for Peripherals
Microchip Technology Incorporated
0 cites
US125457362026
Actrii-binding Proteins and Uses Thereof
Acceleron Pharma Inc
0 cites
US125278392026
Treatments for Systemic Sclerosis
Acceleron Pharma Inc.
0 cites
US124921592025
Method for Producing Levulinic Acid
DEPARTMENT OF BIOTECHNOLOGY
0 cites
US124368892025
Cache Circuit That Selectively Stores Data Blocks to Dynamically Optimize for Read and Write Transactions
QUALCOMM Incorporated
0 cites
US124212952025
Tgf-beta Superfamily Type I and Type II Receptor Heteromultimers and Uses Thereof
Acceleron Pharma Inc.
0 cites
US123647362025
Methods for Treating Heterotopic Ossification
The Regents Of The University Of Michigan
0 cites
US123657362025
ALK7 Binding Proteins and Uses Thereof
Acceleron Pharma Inc.
0 cites
US123433782025
Compositions and Methods for Treating Pulmonary Hypertension
ACCELERON PHARMA Inc.
0 cites
US123382732025
Single-arm Type I and Type II Receptor Fusion Proteins and Uses Thereof
Accerelon Pharma Inc.
0 cites
US122583802025
Alk4:actriib Heteromultimers and Uses Thereof
ACCELERON PHARMA Inc.
0 cites
US122408872025
Variant Actriib Proteins and Uses Thereof
Acceleron Pharma Inc.
0 cites
US121940762025
Methods and Compositions for Treating Myelofibrosis
ACCELERON PHARMA Inc.
0 cites
US121955192025
Transforming Growth Factor-beta (tgf-beta) Receptor Type II Fusion Polypeptides
Acceleron Pharma Inc.
0 cites
US121686832024
Binders of Tgfβ-superfamily Ligands and Uses Thereof
Acceleron Pharma Inc.
0 cites
US121448602024
ALK1 Receptor and Ligand Antagonists and Uses Thereof
ACCELERON PHARMA Inc.
0 cites
US121105302024
Process for Second Generation Lactic Acid Production
Department Of Biotechnology
0 cites
US121039592024
Multispecific Binders of Tgfbeta-superfamily Ligands and Uses Thereof
ACCELERON PHARMA Inc.
0 cites
US120606562024
Capillary Type Multi-jet Nozzle for Fabricating High Throughput Nanofibers
0 cites
US120547532024
Methods of Treatment of Muscular Dystrophy with Alk4:actriib Heteromultimers
ACCELERON PHARMA Inc.
0 cites
US120425242024
Activin Type 2 Receptor Binding Proteins Methods of Making Them
Acceleron Pharma Inc.
0 cites
US120245632024
ALK7 Antagonists and Uses Thereof
Acceleron Pharma Inc.
0 cites
US120142252024
Authorizing Lower Privilege Users to Invoke Privileged Calls
Vmware LLC
0 cites
US119817382024
ALK7 Binding Proteins and Uses Thereof
Acceleron Pharma Inc.
0 cites
US119761112024
Actriia and ALK4 Polypeptides for Treating Kidney Fibrosis, Inflammation and Injury
Acceleron Pharma Inc.
0 cites
US119511562024
Methods for Treating Pulmonary Hypertension with a Ligand Binding Domain of a Tgf-beta Type II Receptor
ACCELERON PHARMA, Inc.
0 cites
US118575992024
Compositions and Methods for Treating Spinal Muscular Atrophy
Acceleron Pharma Inc.
0 cites
US118276892023
Alk7:actriib Heteromultimers and Uses Thereof
ACCELERON PHARMA Inc.
0 cites
US118076732023
Methods and Compositions for Increasing Red Blood Cells
Acceleron Pharma Inc.
0 cites
US117743832023
Quick NMR Method for Identification and Estimation of Components in Hand-rub Formulations
INDIAN OIL CORPORATION LIMITED
0 cites
US117753622023
Content Provisioning to Virtual Machines
Vmware, Inc.
0 cites
US117084142023
ALK7 Binding Proteins and Uses Thereof
Acceleron Pharma Inc.
0 cites
US116629192023
Enhanced Data Clock Operations in Memory
QUALCOMM Incorporated
0 cites
US116423942023
Methods and Compositions Using GDF15 Polypeptides for Increasing Red Blood Cells
ACCELERON PHARMA Inc.
0 cites
US116229922023
Compositions and Methods for Treating Pulmonary Hypertension
ACCELERON PHARMA Inc.
0 cites
US116239372023
Method to Valorize 2G Bioethanol Waste Streams
DEPARTMENT OF BIOTECHNOLOGY
0 cites
US115902012023
Endoglin Peptides to Treat Fibrotic Diseases
ACCELERON PHARMA, Inc.
0 cites